![Addressing the yearly $53B problem for pharma companies using groundbreaking AI and ‘Patient- on-a-chip’ technology](https://industry.pharmafocusasia.com/slider/1719490827-addressing-the-yearly-01.png)
Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG
IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug
Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated
Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta
Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A
BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics
Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness over to years if left untreated Like Alzheimers...
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic
ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed
NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate
Boston, MA, USA
jakarta barat, Indonesia
Jakarta Barat, Indonesia
Songdo Convensia, Incheon, South Korea
Songdo Convensia, Incheon, South Korea
Lisbon, Portugal
London, UK
Co-Founder and CTO, Aventior, Inc
Head of the BioContinuum Platform, MilliporeSigma
Associate Professor and the Head of Career Services and Placement at the School of Pharmacy, Dr. Vishwanath Karad MIT-WPU
Geneticist and Genetic Counselor, MFC Woman and Child Care, West Bengal, India
Assistant Professor, Department of Zoology; Ramakrishna Mission Vivekananda Centenary College, West Bengal, India
Senior Manager Global Scientific Affairs
Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Renaud also serves on several standardisation and pharmacopoeia committees as well as on industry task forcesCancer is the most prevalent cause of death across the globe According to the World Health Organization there is an estimated increase from the anticipated million cases of cancer in It is predicted that more than million
AbstractMixedmode chromatography MMC is a fast growing area in recent years thanks to the new generation of mixedmode stationary phases and better understanding of multimode interactions MMC has superior applications in the separation of compounds that are not retained or not well resolved by typical reversedphase LC methods especially for polar and ch
AbstractObjectivesNational Institute for Health and Care Excellence guidelines recommend immediate antibiotic treatment of respiratory tract infections in atrisk individuals with comorbidities Observational evidence suggests that influenza particularly predisposes children to bacterial comp
Novel cell therapy FCR was developed by Talaris for the treatment of patients with diffuse systemic sclerosis SSc a severe form of the rare autoimmune disease scleroderma
Trial research needs to account for increased complexity and competition when recruiting patients in cancer studies Patients and oncologists have more choices than ever for the placement of qualified study participants Not only are treatments more specialised but the industry
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster